Report overview
This report contains market size and forecasts of Prescription Dermatological Drugs in global, including the following market information:
Global Prescription Dermatological Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prescription Dermatological Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Prescription Dermatological Drugs companies in 2021 (%)
The global Prescription Dermatological Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-acne Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prescription Dermatological Drugs include Johnson & Johnson, Merck, LEO Pharma, Mylan Pharmaceuticals, Pfizer, Roche, Allergan, Bausch Health and PharmaDerm Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prescription Dermatological Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Dermatological Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Dermatological Drugs Market Segment Percentages, by Type, 2021 (%)
Anti-acne Drugs
Anti-aging Drugs
Dermatitis Drugs
Hair Loss Drugs
Psoriasis Drugs
Skin Cancer Drugs
Melasma Drugs
Seborrhea Drugs
Global Prescription Dermatological Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Dermatological Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Prescription Dermatological Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Dermatological Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Dermatological Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prescription Dermatological Drugs revenues share in global market, 2021 (%)
Key companies Prescription Dermatological Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Prescription Dermatological Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Merck
LEO Pharma
Mylan Pharmaceuticals
Pfizer
Roche
Allergan
Bausch Health
PharmaDerm Pharmaceuticals
Allergan Inamed Corporation
